Differential effects of cyclosporine and etretinate on serum cytokine levels in patients with psoriasis
- 1 October 1992
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 27 (4) , 568-574
- https://doi.org/10.1016/0190-9622(92)70224-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Interleukin 1a, Tumor Necrosis Factor a, and Interferon ? in PsoriasisArchives of Dermatology, 1991
- Cyclosporine in dermatologyJournal of the American Academy of Dermatology, 1989
- Cyclosporin A Inhibits Directly In Vivo Keratinocyte Proliferation of Living Human Skin.Journal of Investigative Dermatology, 1989
- Levels of Cyclosporin in Epidermis of Treated Psoriasis Patients Differentially Inhibit Growth of Keratinocytes Cultured in Serum Free Versus Serum Containing MediaJournal of Investigative Dermatology, 1988
- Treatment of resistant severe psoriasis with systemic cyclosporineJournal of the American Academy of Dermatology, 1987
- Effect of orally administered aromatic retinoid on murine Langerhans cellsArchives of Dermatological Research, 1987
- Continuing medical education (Therapy)Journal of the American Academy of Dermatology, 1987
- Interleukin-1-Like Activity in Horny Layer Extracts: Decreased Activity in Scale Extracts of Psoriasis and Sterile Pustular DermatosesDermatology, 1986
- The Effects of Cyclosporin A on the Immune SystemAnnual Review of Immunology, 1985
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981